{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:43:18Z","timestamp":1768873398057,"version":"3.49.0"},"reference-count":32,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T00:00:00Z","timestamp":1396569600000},"content-version":"vor","delay-in-days":34,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology International"],"published-print":{"date-parts":[[2014,3]]},"abstract":"<jats:p><jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>5\u2010positive follicular lymphoma (<jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>), although rare, has been described in a number of case reports. However, a statistically valid, clinicopathological comparison between <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>5\u2010positive <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>5\u2010negative <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> has never been performed because of its rarity. We statistically compared clinicopathological characteristics of 22 cases of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>5\u2010positive <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>, diagnosed by immunohistochemistry, flow cytometry and morphological findings, with those of 62 cases of <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> without <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>5 expression (control cases). <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>5\u2010positive <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> patients showed a higher tendency of peripheral blood involvement (<jats:italic>P<\/jats:italic> = 0.076) and a higher frequency of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>25 expression (<jats:italic>P<\/jats:italic> = 0.0004) and <jats:styled-content style=\"fixed-case\">MUM<\/jats:styled-content>1 protein expression (<jats:italic>P<\/jats:italic> = 0.0008), and a lower frequency of t(14;18)(q32;q21) (<jats:italic>P<\/jats:italic> = 0.017). The overall survival (<jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content>) curve of <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>5\u2010positive <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> was significantly worse than that of control cases (<jats:italic>P<\/jats:italic> = 0.0266), although progression\u2010free survival curves did not show a significant difference (<jats:italic>P<\/jats:italic> = 0.7899). Moreover, <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>5 expression was shown to be an independent poor prognostic factor for <jats:styled-content style=\"fixed-case\">OS<\/jats:styled-content> in both univariate analysis [<jats:styled-content style=\"fixed-case\">H<\/jats:styled-content>azard <jats:styled-content style=\"fixed-case\">R<\/jats:styled-content>atio (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>), 3.63; <jats:italic>P<\/jats:italic> = 0.0464] and multivariate analysis (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>, 57.16; <jats:italic>P<\/jats:italic> = 0.0001). <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>5\u2010positive <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> showed different clinicopathological characteristics from <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> lacking <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>5 expression. These results suggest that <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>5\u2010positive <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content> should be considered a different type of <jats:styled-content style=\"fixed-case\">FL<\/jats:styled-content>, and its clinicopathological management should be conducted differently.<\/jats:p>","DOI":"10.1111\/pin.12145","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T08:28:50Z","timestamp":1396600130000},"page":"95-103","source":"Crossref","is-referenced-by-count":20,"title":["<scp>CD<\/scp>5\u2010positive follicular lymphoma characterized by <scp>CD<\/scp>25, <scp>MUM<\/scp>1, low frequency of t(14;18) and poor prognosis"],"prefix":"10.1111","volume":"64","author":[{"given":"Hiroaki","family":"Miyoshi","sequence":"first","affiliation":[{"name":"Department of Pathology Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensaku","family":"Sato","sequence":"additional","affiliation":[{"name":"Biostatistics Center School of Medicine Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pathology Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshizo","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Pathology Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Kiyasu","sequence":"additional","affiliation":[{"name":"Department of Pathology Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Pathology Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukinao","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Pathology Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiko","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Department of Pathology Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiko","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Pathology Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Pathology Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Niino","sequence":"additional","affiliation":[{"name":"Department of Pathology Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Pathology Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Pathology Kurume University  Kurume Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2007.1.216"},{"key":"e_1_2_6_3_1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Steven HS","year":"2008"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4434"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240406"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(03)00046-3"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2000.00606.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.20.100301.064833"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(99)01476-0"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1309\/V6PJ-BDAP-F0LU-CB6T"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1309\/4KEH-AGY7-UT5H-41XJ"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1309\/U98ADVKUC26R2RJA"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1309\/8EX5B9JFHPEK82BU"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2012.02307.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.2007.02195.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-045989"},{"key":"e_1_2_6_17_1","first-page":"430","article-title":"An uncommon case of de novo CD10+ CD5\u2010 mantle cell lymphoma mimics follicle center B cell lymphoma","volume":"3","author":"Zapata M","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190902842626"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168682"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-198580"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood.V73.5.1259.1259","article-title":"Human normal CD5+ B lymphocytes can be induced to differentiate to CD5\u2010 B lymphocytes with germinal center cell features","volume":"73","author":"Caligaris\u2010Cappio F","year":"1989","journal-title":"Blood"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.141.1.164","article-title":"Inhibitory influence of IL\u20104 on human B cell responsiveness","volume":"141","author":"Jelinek DF","year":"1988","journal-title":"J Immunol"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830190511"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830190212"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1992.tb06936.x"},{"issue":"14","key":"e_1_2_6_26_1","first-page":"S3","article-title":"Cellular and molecular bases of B\u2010cell clonal expansions","volume":"14","author":"Dolcetti R","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400715"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.011049"},{"key":"e_1_2_6_29_1","first-page":"113","article-title":"Related splenic marginal zone lymphomas with peripheral CD5 expression","volume":"89","author":"Giannouli S","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP27YWLIQRAJPW"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2006.02501.x"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq057"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-7563.2011.01432.x"}],"container-title":["Pathology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpin.12145","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pin.12145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T14:53:07Z","timestamp":1696171987000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pin.12145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["10.1111\/pin.12145"],"URL":"https:\/\/doi.org\/10.1111\/pin.12145","archive":["Portico"],"relation":{},"ISSN":["1320-5463","1440-1827"],"issn-type":[{"value":"1320-5463","type":"print"},{"value":"1440-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}